deaths (OS)

mUC - L1 - all population metastatic/advanced UC (mUC) - 1st Line (L1) mUC - L1 - all population

versus gemcitabine plus platin
durvalumab plus tremelimumab vs. gemcitabine plus platin 1 certainty unassessable-14%